Cargando…
Oxaliplatin Causes Transient Changes in TRPM8 Channel Activity
Oxaliplatin is a third-generation platinum-based anticancer drug that is widely used as first-line treatment for colorectal carcinoma. Patients treated with oxaliplatin develop an acute peripheral pain several hours after treatment, mostly characterized by cold allodynia as well as a long-term chron...
Autores principales: | Rimola, Vittoria, Osthues, Tabea, Königs, Vanessa, Geißlinger, Gerd, Sisignano, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125753/ https://www.ncbi.nlm.nih.gov/pubmed/34066977 http://dx.doi.org/10.3390/ijms22094962 |
Ejemplares similares
-
The Lipid Receptor G2A (GPR132) Mediates Macrophage Migration in Nerve Injury-Induced Neuropathic Pain
por: Osthues, Tabea, et al.
Publicado: (2020) -
Oxidized Lipids in Persistent Pain States
por: Osthues, Tabea, et al.
Publicado: (2019) -
The G2A receptor (GPR132) contributes to oxaliplatin-induced mechanical pain hypersensitivity
por: Hohmann, Stephan W., et al.
Publicado: (2017) -
The G2A Receptor Controls Polarization of Macrophage by Determining Their Localization Within the Inflamed Tissue
por: Kern, Katharina, et al.
Publicado: (2018) -
Drug Repurposing to Target Neuroinflammation and Sensory Neuron-Dependent Pain
por: Sisignano, Marco, et al.
Publicado: (2022)